-+ 0.00%
-+ 0.00%
-+ 0.00%

Scienture names Narasimhan Mani interim CFO after Eric Sherb resigns

PUBT·05/29/2026 21:01:45
Listen to the news
Scienture names Narasimhan Mani interim CFO after Eric Sherb resigns
  • Scienture Holdings named Dr. Narasimhan Mani interim CFO effective May 26, 2026.
  • He replaces Eric Sherb, who resigned as CFO May 26 for personal reasons.
  • Mani has been a director, co-CEO, and president since May 2025, overseeing operations including financial planning and reporting.
  • He previously led Kesin Pharma as CEO, ran Xiromed, and held a strategy and business development role at Amneal Pharmaceuticals.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scienture Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-026414), on May 29, 2026, and is solely responsible for the information contained therein.